Showing 541 - 560 results of 145,681 for search '(( 10 ((nm decrease) OR (a decrease)) ) OR ( 50 ((we decrease) OR (nn decrease)) ))', query time: 0.78s Refine Results
  1. 541
  2. 542
  3. 543
  4. 544
  5. 545
  6. 546
  7. 547

    RNAi of electron transport chain components in glutamate neurons decreases nighttime activity in 10 day old flies. by Jessie E. Landis (16378731)

    Published 2023
    “…(A) Average activity over 24 hours in a LD cycle saw a decrease of 32% (p = 0.029) and 39% (p = 0.005) in RNAi targeting <i>CG9172</i> and <i>CG5389</i>. …”
  8. 548
  9. 549
  10. 550
  11. 551

    MiR-10a-5p expression was reduced and miR-10a-5p overexpression was correlated with longer OS in melanoma. by Haijun Zhu (533051)

    Published 2021
    “…<b>(C)</b> qRT-PCR assay was used to assess the expression of the eight DEMsin A375, B16-F10, HeMa-Lp and melan-a cell lines. …”
  12. 552
  13. 553
  14. 554
  15. 555
  16. 556
  17. 557

    DataSheet_1_IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibod... by Adela Navrátilová (11589532)

    Published 2021
    “…Synovial fibroblasts exposed to IL-40 increased the secretion of IL-8 (p<0.01), MCP-1 (p<0.05), and MMP-13 (p<0.01) compared to the unstimulated cells.</p>Conclusions<p>We show the up-regulation of IL-40 in RA and its decrease following B cell depleting therapy. …”
  18. 558
  19. 559

    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis by Yongqiang Sun (8226111)

    Published 2024
    “…Among them, compound <b>LQ23</b> showed more elevated inhibitory activity against CLK2 than the lead compound (IC<sub>50</sub>, 1.4 nM) with high CLK2/CLK3 selectivity (>70-fold). …”
  20. 560

    Structure-Guided Discovery of Potent and Selective CLK2 Inhibitors for the Treatment of Knee Osteoarthritis by Yongqiang Sun (8226111)

    Published 2024
    “…Among them, compound <b>LQ23</b> showed more elevated inhibitory activity against CLK2 than the lead compound (IC<sub>50</sub>, 1.4 nM) with high CLK2/CLK3 selectivity (>70-fold). …”